These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 6471780)
21. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII). Garcia VV; Silva IA; Borrasca AL Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999 [TBL] [Abstract][Full Text] [Related]
22. Subcutaneous injection of desmopressin (DDAVP): evaluation of a new, more concentrated preparation. Köhler M; Hellstern P; Tarrach H; Bambauer R; Wenzel E; Jutzler GA Haemostasis; 1989; 19(1):38-44. PubMed ID: 2493411 [TBL] [Abstract][Full Text] [Related]
23. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities. Moffat EH; Giddings JC; Bloom AL Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337 [TBL] [Abstract][Full Text] [Related]
24. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion. Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998 [TBL] [Abstract][Full Text] [Related]
25. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease]. Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405 [TBL] [Abstract][Full Text] [Related]
26. Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses. Mannucci PM; Vicente V; Alberca I; Sacchi E; Longo G; Harris AS; Lindquist A Thromb Haemost; 1987 Dec; 58(4):1037-9. PubMed ID: 3127916 [TBL] [Abstract][Full Text] [Related]
27. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease. Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599 [TBL] [Abstract][Full Text] [Related]
28. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. Casonato A; Sartori MT; de Marco L; Girolami A Thromb Haemost; 1990 Aug; 64(1):117-20. PubMed ID: 2274916 [TBL] [Abstract][Full Text] [Related]
29. 1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease. McKeown LP; Connaghan G; Wilson O; Hansmann K; Merryman P; Gralnick HR Am J Hematol; 1996 Feb; 51(2):158-63. PubMed ID: 8579058 [TBL] [Abstract][Full Text] [Related]
30. The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders. Mörsdorf S; Köhler M; Leipnitz G; Wenzel E Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):503-7. PubMed ID: 2465962 [TBL] [Abstract][Full Text] [Related]
31. [Progress in the treatment of mild hemophilia. Liberation of factor VIII from the vascular endothelium with 1-desamino-8-D-arginine vasopressin]. Tjønnfjord GE; Evensen SA; Stormorken H; Trebo S Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1291-2. PubMed ID: 2499950 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease. Gill JC; Ottum M; Schwartz B J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528 [TBL] [Abstract][Full Text] [Related]
34. Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors. Lethagen S; Ragnarson Tennvall G Ann Hematol; 1993 May; 66(5):257-60. PubMed ID: 8507721 [TBL] [Abstract][Full Text] [Related]
35. New ways to boost factor VIII in hemophilia: DDAVP for mild hemophilia A, von Willebrand's. Marwick C JAMA; 1983 Jun; 249(24):3278-9. PubMed ID: 6406692 [No Abstract] [Full Text] [Related]
37. The effect of intranasal DDAVP on coagulation and fibrinolytic activity in normal persons. Nilsson IM; Mikaelsson M; Vilhardt H Scand J Haematol; 1982 Jul; 29(1):70-4. PubMed ID: 6812213 [TBL] [Abstract][Full Text] [Related]
38. Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease. White B; Lawler P; Riddell A; Nitu-Whalley IC; Hermans C; Lee CA; Brown SA Br J Haematol; 2004 Jul; 126(1):100-4. PubMed ID: 15198739 [TBL] [Abstract][Full Text] [Related]
39. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139 [TBL] [Abstract][Full Text] [Related]
40. [DDAVP: alternative to replacement treatment in mild haemophilia A and von Willebrand-Jürgens syndrome (author's transl)]. Theiss W; Sauer E Dtsch Med Wochenschr; 1977 Dec; 102(48):1769-72. PubMed ID: 303563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]